Cargando…

Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging

OBJECTIVES: We examined the effects of aging and of gadolinium-based contrast agent (GBCA) exposure on MRI measurements in brain nuclei of healthy women. METHODS: This prospective, IRB-approved single-center case-control study enrolled 100 healthy participants of our high-risk screening center for h...

Descripción completa

Detalles Bibliográficos
Autores principales: Krug, Kathrin Barbara, Burke, Christina Jane, Weiss, Kilian, Baltzer, Pascal A. T., Rhiem, Kerstin, Maintz, David, Schlamann, Marc, Hellmich, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660719/
https://www.ncbi.nlm.nih.gov/pubmed/34218287
http://dx.doi.org/10.1007/s00330-021-08069-4
_version_ 1784613247029084160
author Krug, Kathrin Barbara
Burke, Christina Jane
Weiss, Kilian
Baltzer, Pascal A. T.
Rhiem, Kerstin
Maintz, David
Schlamann, Marc
Hellmich, Martin
author_facet Krug, Kathrin Barbara
Burke, Christina Jane
Weiss, Kilian
Baltzer, Pascal A. T.
Rhiem, Kerstin
Maintz, David
Schlamann, Marc
Hellmich, Martin
author_sort Krug, Kathrin Barbara
collection PubMed
description OBJECTIVES: We examined the effects of aging and of gadolinium-based contrast agent (GBCA) exposure on MRI measurements in brain nuclei of healthy women. METHODS: This prospective, IRB-approved single-center case-control study enrolled 100 healthy participants of our high-risk screening center for hereditary breast cancer, who had received at least six doses of macrocyclic GBCA (exposed group) or were newly entering the program (GBCA-naïve group). The cutoff “at least six doses” was chosen to be able to include a sufficient number of highly exposed participants. All participants underwent unenhanced 3.0-T brain MRI including quantitative T1, T2, and R2* mapping and T1- and T2-weighted imaging. The relaxation times/signal intensities were derived from region of interest measurements in the brain nuclei performed by a radiologist and a neuroradiologist, both board certified. Statistical analysis was based on descriptive evaluations and uni-/multivariable analyses. RESULTS: The participants (exposed group: 49, control group: 51) were aged 42 ± 9 years. In a multivariable model, age had a clear impact on R2* (p < 0.001–0.012), T2 (p = 0.003–0.048), and T1 relaxation times/signal intensities (p < 0.004–0.046) for the majority of deep brain nuclei, mostly affecting the substantia nigra, globus pallidus (GP), nucleus ruber, thalamus, and dentate nucleus (DN). The effect of prior GBCA administration on T1 relaxation times was statistically significant for the DN, GP, and pons (p = 0.019–0.037). CONCLUSIONS: In a homogeneous group of young to middle-aged healthy females aging had an effect on T2 and R2* relaxation times and former GBCA applications influenced the measured T1 relaxation times. KEY POINTS: The quantitative T1, T2, and R2* relaxation times measured in women at high risk of developing breast cancer showed characteristic bandwidth for all brain nuclei examined at 3.0-T MRI. The effect of participant age had a comparatively strong impact on R2*, T2, and T1 relaxation times for the majority of brain nuclei examined. The effect of prior GBCA administrations on T1 relaxation times rates was comparatively less pronounced, yielding statistically significant results for the dentate nucleus, globus pallidus, and pons. SUMMARY STATEMENT: Healthy women with and without previous GBCA-enhanced breast MRI exhibited age-related T2* and T2 relaxation alterations at 3.0 T-brain MRI. T1 relaxation alterations due to prior GBCA administration were comparatively less pronounced. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-021-08069-4.
format Online
Article
Text
id pubmed-8660719
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-86607192021-12-27 Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging Krug, Kathrin Barbara Burke, Christina Jane Weiss, Kilian Baltzer, Pascal A. T. Rhiem, Kerstin Maintz, David Schlamann, Marc Hellmich, Martin Eur Radiol Contrast Media OBJECTIVES: We examined the effects of aging and of gadolinium-based contrast agent (GBCA) exposure on MRI measurements in brain nuclei of healthy women. METHODS: This prospective, IRB-approved single-center case-control study enrolled 100 healthy participants of our high-risk screening center for hereditary breast cancer, who had received at least six doses of macrocyclic GBCA (exposed group) or were newly entering the program (GBCA-naïve group). The cutoff “at least six doses” was chosen to be able to include a sufficient number of highly exposed participants. All participants underwent unenhanced 3.0-T brain MRI including quantitative T1, T2, and R2* mapping and T1- and T2-weighted imaging. The relaxation times/signal intensities were derived from region of interest measurements in the brain nuclei performed by a radiologist and a neuroradiologist, both board certified. Statistical analysis was based on descriptive evaluations and uni-/multivariable analyses. RESULTS: The participants (exposed group: 49, control group: 51) were aged 42 ± 9 years. In a multivariable model, age had a clear impact on R2* (p < 0.001–0.012), T2 (p = 0.003–0.048), and T1 relaxation times/signal intensities (p < 0.004–0.046) for the majority of deep brain nuclei, mostly affecting the substantia nigra, globus pallidus (GP), nucleus ruber, thalamus, and dentate nucleus (DN). The effect of prior GBCA administration on T1 relaxation times was statistically significant for the DN, GP, and pons (p = 0.019–0.037). CONCLUSIONS: In a homogeneous group of young to middle-aged healthy females aging had an effect on T2 and R2* relaxation times and former GBCA applications influenced the measured T1 relaxation times. KEY POINTS: The quantitative T1, T2, and R2* relaxation times measured in women at high risk of developing breast cancer showed characteristic bandwidth for all brain nuclei examined at 3.0-T MRI. The effect of participant age had a comparatively strong impact on R2*, T2, and T1 relaxation times for the majority of brain nuclei examined. The effect of prior GBCA administrations on T1 relaxation times rates was comparatively less pronounced, yielding statistically significant results for the dentate nucleus, globus pallidus, and pons. SUMMARY STATEMENT: Healthy women with and without previous GBCA-enhanced breast MRI exhibited age-related T2* and T2 relaxation alterations at 3.0 T-brain MRI. T1 relaxation alterations due to prior GBCA administration were comparatively less pronounced. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00330-021-08069-4. Springer Berlin Heidelberg 2021-07-03 2022 /pmc/articles/PMC8660719/ /pubmed/34218287 http://dx.doi.org/10.1007/s00330-021-08069-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Contrast Media
Krug, Kathrin Barbara
Burke, Christina Jane
Weiss, Kilian
Baltzer, Pascal A. T.
Rhiem, Kerstin
Maintz, David
Schlamann, Marc
Hellmich, Martin
Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging
title Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging
title_full Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging
title_fullStr Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging
title_full_unstemmed Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging
title_short Influence of aging and gadolinium exposure on T1, T2, and T2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-T brain MR imaging
title_sort influence of aging and gadolinium exposure on t1, t2, and t2*-relaxation in healthy women with an increased risk of breast cancer with and without prior exposure to gadoterate meglumine at 3.0-t brain mr imaging
topic Contrast Media
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660719/
https://www.ncbi.nlm.nih.gov/pubmed/34218287
http://dx.doi.org/10.1007/s00330-021-08069-4
work_keys_str_mv AT krugkathrinbarbara influenceofagingandgadoliniumexposureont1t2andt2relaxationinhealthywomenwithanincreasedriskofbreastcancerwithandwithoutpriorexposuretogadoteratemeglumineat30tbrainmrimaging
AT burkechristinajane influenceofagingandgadoliniumexposureont1t2andt2relaxationinhealthywomenwithanincreasedriskofbreastcancerwithandwithoutpriorexposuretogadoteratemeglumineat30tbrainmrimaging
AT weisskilian influenceofagingandgadoliniumexposureont1t2andt2relaxationinhealthywomenwithanincreasedriskofbreastcancerwithandwithoutpriorexposuretogadoteratemeglumineat30tbrainmrimaging
AT baltzerpascalat influenceofagingandgadoliniumexposureont1t2andt2relaxationinhealthywomenwithanincreasedriskofbreastcancerwithandwithoutpriorexposuretogadoteratemeglumineat30tbrainmrimaging
AT rhiemkerstin influenceofagingandgadoliniumexposureont1t2andt2relaxationinhealthywomenwithanincreasedriskofbreastcancerwithandwithoutpriorexposuretogadoteratemeglumineat30tbrainmrimaging
AT maintzdavid influenceofagingandgadoliniumexposureont1t2andt2relaxationinhealthywomenwithanincreasedriskofbreastcancerwithandwithoutpriorexposuretogadoteratemeglumineat30tbrainmrimaging
AT schlamannmarc influenceofagingandgadoliniumexposureont1t2andt2relaxationinhealthywomenwithanincreasedriskofbreastcancerwithandwithoutpriorexposuretogadoteratemeglumineat30tbrainmrimaging
AT hellmichmartin influenceofagingandgadoliniumexposureont1t2andt2relaxationinhealthywomenwithanincreasedriskofbreastcancerwithandwithoutpriorexposuretogadoteratemeglumineat30tbrainmrimaging